These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Purification, characterization and reaction mechanism of novel arylsulfotransferase obtained from an anaerobic bacterium of human intestine. Kim DH; Konishi L; Kobashi K Biochim Biophys Acta; 1986 Jul; 872(1-2):33-41. PubMed ID: 3460636 [TBL] [Abstract][Full Text] [Related]
27. Acetaminophen and phenol: substrates for both a thermostable and a thermolabile form of human platelet phenol sulfotransferase. Reiter C; Weinshilboum RM J Pharmacol Exp Ther; 1982 Apr; 221(1):43-51. PubMed ID: 6950087 [No Abstract] [Full Text] [Related]
29. Human liver and conjugation of catecholamines. Tyce GM; Van Dyke RA; Rettke SR; Atchison SR; Wiesner RH; Dickson ER; Krom RA J Lab Clin Med; 1987 May; 109(5):532-7. PubMed ID: 3553391 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of phenolsulphotransferase P by certain food constituents. Gibb C; Glover V; Sandler M Lancet; 1986 Apr; 1(8484):794. PubMed ID: 2870281 [No Abstract] [Full Text] [Related]
31. A hydroxymethyl sulphate ester as an active metabolite of the carcinogen, 5-hydroxymethylchrysene. Okuda H; Hiratsuka A; Nojima H; Watabe T Biochem Pharmacol; 1986 Feb; 35(3):535-8. PubMed ID: 3456226 [No Abstract] [Full Text] [Related]
32. Dose-dependent shifts in the sulfation and glucuronidation of phenolic compounds in the rat in vivo and in isolated hepatocytes. The role of saturation of phenolsulfotransferase. Koster H; Halsema I; Scholtens E; Knippers M; Mulder GJ Biochem Pharmacol; 1981 Sep; 30(18):2569-75. PubMed ID: 6946775 [No Abstract] [Full Text] [Related]
35. Sulfonation of raloxifene in HEK293 cells overexpressing SULT1A3: Involvement of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in excretion of sulfate metabolites. Zhou X; Wang S; Sun H; Wu B Drug Metab Pharmacokinet; 2015 Dec; 30(6):425-33. PubMed ID: 26611713 [TBL] [Abstract][Full Text] [Related]
36. Phytoestrogens are potent inhibitors of estrogen sulfation: implications for breast cancer risk and treatment. Harris RM; Wood DM; Bottomley L; Blagg S; Owen K; Hughes PJ; Waring RH; Kirk CJ J Clin Endocrinol Metab; 2004 Apr; 89(4):1779-87. PubMed ID: 15070945 [TBL] [Abstract][Full Text] [Related]